Based in part on protein structures determined at the National Synchrotron Light Source at the US Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class. These peptides are sufficiently potent to begin preclinical studies as a new class of agents for the prevention and treatment of HIV/AIDS.
Post new comment